News Archive

25 Jun 2024

RoslinCT appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors

18 Jan 2024

Well-placed to lead in advanced therapies for complex diseases

28 Nov 2023

RoslinCT to manufacture world’s-first CRISPR-based therapy for Vertex

30 Aug 2023

BioQuarter Bulletin August 2023

15 Jun 2023

BioQuarter Bulletin June 2023

12 Apr 2023

April 2023 BioQuarter Bulletin

30 Mar 2023

RoslinCT granted commercial manufacturing license

17 Mar 2023

University of Edinburgh innovators triumph at Scotland’s Life Sciences Awards

31 Jan 2023

Latest issue of BioQuarter Bulletin

04 Nov 2022

November issue of BioQuarter Bulletin